Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Aadi Bioscience | 3350 | Apr 25, 2025 | 1.27 | -2.31 |
AAK | 6AA0 | Apr 25, 2025 | 22.62 | -7.37 |
Aalberts NV | AACA | Apr 25, 2025 | 28.54 | +6.65 |
Aallon Group | I74 | Apr 25, 2025 | 10.00 | -0.50 |
AAP Implantate AG | AAQ1 | Apr 25, 2025 | 1.49 | +5.67 |
AAR Corp. | ARZ | Apr 25, 2025 | 46.04 | -0.86 |
AB Akola Group | YG4 | Apr 25, 2025 | 1.04 | -1.42 |
AB Amber Grid | AMH | Apr 25, 2025 | 1.20 | 0.00 |
AB Dynamics plc | 6DY | Apr 25, 2025 | 19.70 | +5.91 |
AB Ignitis Grupe | IGV0 | Apr 25, 2025 | 20.10 | -2.19 |
AB S.A. | 8B6 | Apr 25, 2025 | 22.30 | +1.13 |
Ab Science | A8D | Apr 25, 2025 | 1.44 | +5.41 |
ABACUS GRP UTS | EZO1 | Apr 25, 2025 | 0.63 | +3.36 |
Abacus Mining & Exploration Corp. | DGV2 | Apr 25, 2025 | 0.01 | 0.00 |
ABB Ltd | ABJA | Apr 25, 2025 | 46.00 | +4.78 |
ABB LTD. CDR O.N. | ABJ3 | Apr 25, 2025 | 15.60 | 0.00 |
Abbott Laboratories | ABL | Apr 25, 2025 | 113.56 | -2.37 |
AbbVie Inc. | 4AB | Apr 25, 2025 | 160.40 | +5.11 |
ABC | EK7 | Apr 25, 2025 | 0.52 | +4.92 |
ABC Arbitrage | 9BA | Apr 25, 2025 | 5.93 | +1.02 |
ABC-Mart Inc. | 5B8 | Apr 25, 2025 | 15.80 | -0.63 |
AbCellera Biologics Inc. - | 8QQ | Apr 25, 2025 | 2.27 | +3.80 |
Abcourt Mines, Inc. | AML | Apr 25, 2025 | 0.03 | +14.81 |
ABEN MINERALS LTD | R26 | Apr 25, 2025 | 0.03 | 0.00 |
Abercrombie & Fitch Company | AFT | Apr 25, 2025 | 64.00 | +5.45 |
Aberdeen Asia-Pacificome Fund | 9J90 | Apr 25, 2025 | 12.95 | +2.21 |
Aberdeen International Inc | A8H | Apr 25, 2025 | 0.01 | -27.27 |
Aberdeen Standard European Logistics Income Plc | 5JX | Apr 25, 2025 | 0.64 | +1.59 |
Aberforth Smaller Companies Trust PLC | 0KJ | Apr 25, 2025 | 15.70 | +3.97 |
ABG Sundal Collier Holding | DAB | Apr 25, 2025 | 0.53 | -3.28 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.